Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro

Research in Veterinary Science

Volumn 88, Issue 2, 2010, Pages 339-344

  Dal Pozzo, Fabiana ^a   Galligioni, Viola ^a   Vaccari, Francesca ^a   Gallina, Laura ^a   Battilani, Mara ^a   Scagliarini, Alessandra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiviral activity; Canine distemper virus; EICAR; Mechanism of action; Paramyxoviridae; Ribavirin

Indexed keywords

5 ETHYNYL 4 IMIDAZOLECARBOXAMIDE 1 RIBOSIDE; GUANOSINE; INOSINATE DEHYDROGENASE; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; IC 50; NONHUMAN; PARAMYXOVIRUS; VERO CELL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DISTEMPER VIRUS, CANINE; DOSE-RESPONSE RELATIONSHIP, DRUG; RIBAVIRIN; RIBONUCLEOSIDES; VERO CELLS;

CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; PARAMYXOVIRIDAE;

EID: 76849110390     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.08.010     Document Type: Article

References (27)

1. Appel M.J.G. Canine distemper virus. In: Appel M.J.G. (Ed). Virus Infection of Carnivores vol. 1 (1987), Elsevier Science, Amsterdam, The Netherlands 133-159
2. Benarroch D., Egloff M.P., Mulard L., Guerreiro C., Romette J.L., and Canard B. A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate. Journal of Biological Chemistry 279 (2004) 35638-35643
3. Bourhis J.M., Canard B., and Longhi S. Structural disorder within the replicative complex of measles virus: functional implications. Virology 344 (2006) 94-110
4. Bussell R.H., and Karzon D.T. Canine distemper virus in primary and continuous cell lines of human and monkey origin. Archiv für die gesamte Virusforschung 17 (1965) 183-202
5. Crotty S., Cameron C.E., and Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 6895-6900
6. De Clercq E., Cools M., Balzarini J., Snoeck R., Andrei G., Hosoya M., Shigeta S., Ueda T., Minakawa N., and Matsuda A. Antiviral activities of 5-ethynyl-1-beta-d-ribofuranosylimidazole-4-carboxamide and related compounds. Antimicrobial Agents and Chemotherapy 35 (1991) 679-684
7. del Toro-Riera M., Macaya-Ruiz A., Raspall-Chaure M., Tallada-Serra M., Pasqual-López I., and Roig-Quilis M. Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin. Revista de Neurologia 42 (2006) 277-281
8. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 89 (1986) 271-277
9. Elia G., Belloli C., Cirone F., Lucente M.S., Caruso M., Martella V., Decaro N., Buonavoglia C., and Ormas P. In vitro efficacy of ribavirin against canine distemper virus. Antiviral Research 77 (2007) 108-113
10. Fang S.H., Hwang L.H., Chen D.S., and Chiang B.L. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. Journal of Hepatology 33 (2000) 791-798
11. Goswami B.B., Borek E., Sharma O.K., Fujitaki J., and Smith R.A. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochemical and Biophysical Research Communications 89 (1979) 830-836
12. Haig D.A. Preliminary note on the cultivation of green's distemperoid virus in fertile hen eggs. The Onderstepoort Journal of Veterinary Science and Animal Industry 23 (1948) 149-155
13. Hosoya M., Mori S., Tomoda A., Mori K., Sawaishi Y., Kimura H., Shigeta S., and Suzuki H. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrobial Agents and Chemotherapy 48 (2004) 4631-4635
14. Leyssen P., Balzarini J., De Clercq E., and Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. Journal of Virology 79 (2005) 1943-1947
15. Maag D., Castro C., Hong Z., and Cameron C.E. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. Journal of Biological Chemistry 276 (2001) 46094-46098
16. Martella V., Elia G., and Buonavoglia C. Canine distemper virus. The Veterinary Clinics of North America. Small Animal Practice 38 (2008) 787-797
17. Osterhaus A.D., Groen J., De Vries P., UytdeHaag F.G., Klingeborn B., and Zarnke R. Canine distemper virus in seals. Nature 335 (1988) 403-404
18. Patterson J.L., and Fernandez-Larsson R. Molecular mechanisms of action of ribavirin. Reviews of infectious diseases 12 (1990) 1139-1146
19. Plumet S., Duprex W.P., and Gerlier D. Dynamics of viral RNA synthesis during measles virus infection. Journal of Virology 79 (2005) 6900-6908
20. Scagliarini A., Vaccari F., Gallina L., Dal Pozzo F., and Prosperi S. In vitro evaluation of antiviral activity of ribavirin against canine distemper virus. Veterinary Research Communications 30 supplement 1 (2006) 269-272
21. Scagliarini A., Dal Pozzo F., Gallina L., Vaccari F., and Morganti L. TaqMan based real time PCR for the quantification of canine distemper virus. Veterinary Research Communications 31 supplement 1 (2007) 261-263
22. Shigeta S., Mori S., Baba M., Ito M., Honzumi K., Nakamura K., Oshitani H., Numazaki Y., Matsuda A., and Obara T. Antiviral activities of ribavirin, 5-ethynyl-1-beta-d-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrobial Agents and Chemotherapy 36 (1992) 435-439
23. Sun A., Chandrakumar N., Yoon J.J., Plemper R.K., and Snyder J.P. Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: synthesis and in vitro evaluation. Bioorganic and Medicinal Chemistry Letters 17 (2007) 5199-5203
24. Vandevelde M., and Zurbriggen A. The neurobiology of canine distemper virus infection. Veterinary Microbiology 44 (1995) 271-280
25. Vandevelde M., Kristensen B., Braund K.G., Greene C.E., Swango L.J., and Hoerlein B.F. Chronic canine distemper virus encephalitis in mature dogs. Veterinary Pathology 17 (1980) 17-28
26. White L.K., Yoon J.J., Lee J.K., Sun A., Du Y., Fu H., Snyder J.P., and Plemper R.K. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity. Antimicrobial Agents and Chemotherapy 51 (2007) 2293-2303
27. Yoon J.J., Chawla D., Paal T., Ndungu M., Du Y., Kurtkaya S., Sun A., Snyder J.P., and Plemper R.K. High-throughput screening-based identification of paramyxovirus inhibitors. Journal of Biomolecular Screening 13 (2008) 591-608